Email Updates

You are here

AVAC in the News

  • Global funding for COVID-19 vaccine development has exceeded 10 times in less than a year the amount allocated for HIV and TB research and development in 11 years.

    February 6, 2021
    The International News
  • When Wasiu spoke to Devex in 2018 about his HIV-positive status and the statuses of his three wives, the two living with him in Nigeria had tested positive for HIV while the one in the United States was HIV-negative due to distance and her ability to access pre-exposure prophylaxis, or PrEP.

    February 5, 2021
  • Nearly 1 million people are now taking pre-exposure prophylaxis (PrEP), medicine that can slash the risk of HIV infections. While early use of the drug was mostly limited to Western nations, the number of users in sub-Saharan Africa (SSA) has now drastically increased, accounting for more than half of the world’s PrEP users.

    February 2, 2021
    New Scientist
  • Despite the incredible efficacy of oral pre-exposure prophylaxis (PrEP) and 78 countries currently offering PrEP in some form, its effectiveness at reducing HIV incidence in the real world has been dependent on far-reaching factors that go beyond how well PrEP is able to prevent HIV acquisition at a cellular level: political leadership, quality health services and funding.

    February 1, 2021
  • South Africa is ahead of local targets in rolling out the HIV prevention pill. Meanwhile, options for HIV prevention are expanding — though the devil is in the detail of getting medicines to people in a way that works for them.

    January 27, 2021
    Daily Maverick
  • New pivotal research, the first of its kind to announce results, builds on ideas from vaccination and tests a new idea: whether special antibodies — the type that can help someone fight off multiple forms of the virus — can be used to prevent HIV infection.

    January 27, 2021
    Antibody Related Research
  • While global attention has fixated on the coronavirus, the forty-year long fight against HIV, which has claimed 33 million lives, is seeing new breakthroughs in preventive tools. New discoveries of “broadly neutralizing antibodies” as well as novel regimens of pre-exposure prophylaxis (PrEP), could strengthen the world’s toolbox to prevent the disease, announced the International AIDS Society (IAS) at the opening of the 4th HIV Research for Prevention Conference.

    January 27, 2021
    Antibody Related Research, PrEP
    Health Policy Watch
  • HIV PrEP uptake has increased sixfold globally in the last 4 years but remains short of the UNAIDS target of 3 million users, according to data reported during the HIV Research for Prevention virtual conference.

    January 26, 2021
  • “The enormity of the problem is how I keep going,” Dr Anthony Fauci told a meeting of global health journalists yesterday. “I haven’t had a single day off since 20th January last year, but the necessity of dealing with the COVID epidemic is an anaesthetic against fatigue.”

    January 14, 2021
  • Sports teams have faced intense blowback since the spring over the perception that they have received special treatment in a pandemic. Now some public health experts are weighing a counterintuitive idea for how they could help end it.

    December 6, 2020
    Wall Street Journal